PR vs VRTX · P/E 21, rev $5.00B vs P/E 30, rev $12.00B
Permian Resources Corporation (PR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Permian Resources Corporation (PR) is a oil & gas e&p company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported PR revenue for 2024-12-31 was $5.00B. Net income was $1.25B. Revenue was up 60.2% from 2023-12-31 to 2024-12-31. PR currently screens at market cap $15.99B and trailing P/E 20.9.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
PR currently screens at market cap $15.99B and trailing P/E 20.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the PR and VRTX stock pages for the full models.
Not investment advice.